Hokkaido University Collection of Scholarly and Academic Papers >
Institute for Genetic Medicine >
Peer-reviewed Journal Articles, etc >
Preventive Effect of Lactobacillus helveticus SBT2171 on Collagen-Induced Arthritis in Mice
This item is licensed under:Creative Commons Attribution 4.0 International
Title: | Preventive Effect of Lactobacillus helveticus SBT2171 on Collagen-Induced Arthritis in Mice |
Authors: | Yamashita, Maya Browse this author | Matsumoto, Kurumi Browse this author | Endo, Tsutomu Browse this author | Ukibe, Ken Browse this author | Hosoya, Tomohiro Browse this author | Matsubara, Yumi Browse this author | Nakagawa, Hisako Browse this author | Sakai, Fumihiko Browse this author | Miyazaki, Tadaaki Browse this author →KAKEN DB |
Keywords: | Lactobacillus helveticus SBT2171 | rheumatoid arthritis | collagen-induced arthritis | autoantibody production | pro-inflammatory cytokines |
Issue Date: | 21-Jun-2017 |
Publisher: | Frontiers Media |
Journal Title: | Frontiers in microbiology |
Volume: | 8 |
Start Page: | 1159 |
Publisher DOI: | 10.3389/fmicb.2017.01159 |
Abstract: | We recently reported that the intraperitoneal inoculation of Lactobacillus helveticus SBT2171 inhibited the development of collagen-induced arthritis (CIA), a murine model of rheumatoid arthritis (RA). In the present study, we evaluated the effect of the oral administration of L. helveticus SBT2171 on CIA development and on the regulation of antigen-specific antibody production and inflammatory immune cells, which have been implicated in the development of RA. Both oral administration and intraperitoneal inoculation of L. helveticus SBT2171 reduced joint swelling, body weight loss, and the serum level of bovine type II collagen (CII)-specific antibodies in the CIA mouse model. The intraperitoneal inoculation also decreased the arthritis incidence, joint damage, and serum level of interleukin (IL)-6. In addition, the numbers of total immune cells, total B cells, germinal center B cells, and CD4+ T cells in the draining lymph nodes were decreased following intraperitoneal inoculation of L. helveticus SBT2171. These findings demonstrate the ability of L. helveticus SBT2171 to downregulate the abundance of immune cells and the subsequent production of CII-specific antibodies and IL-6, thereby suppressing the CIA symptoms, indicating its potential for use in the prevention of RA. |
Rights: | http://creativecommons.org/licenses/by/4.0/ |
Type: | article |
URI: | http://hdl.handle.net/2115/66984 |
Appears in Collections: | 遺伝子病制御研究所 (Institute for Genetic Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 宮崎 忠昭
|